PCOS drug study pulled before it began
NCT ID NCT06222437
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test semaglutide in women with polycystic ovary syndrome (PCOS) to see if it helps with weight and treatment adherence. It was designed for women aged 18-45 with a BMI over 30. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Weight-Loss drug tame PCOS hormones?
- Could interval training and fasting tame PCOS insulin resistance?
- New PCOS study aims to map hidden patterns of the condition
- New hope for PCOS: extended letrozole or adding inositol may help ovulation
- New hope for PCOS: supplement combo aims to restore ovulation
- Could a protein boost make a PCOS supplement work better?